Article | Open | Published:

KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis

Cell Death & Diseasevolume 10, Article number: 68 (2019) | Download Citation

Abstract

KDM4/JMJD2 Jumonji C-containing histone lysine demethylases (KDM4A–D) constitute an important class of epigenetic modulators in the transcriptional activation of cellular processes and genome stability. Interleukin-8 (IL-8) is overexpressed in gastric cancer, but the mechanisms and particularly the role of the epigenetic regulation of IL-8, are unclear. Here, we report that KDM4B, but not KDM4A/4C, upregulated IL-8 production in the absence or presence of Helicobacter pylori. Moreover, KDM4B physically interacts with c-Jun on IL-8, MMP1, and ITGAV promoters via its demethylation activity. The depletion of KDM4B leads to the decreased expression of integrin αV, which is exploited by H. pylori carrying the type IV secretion system, reducing IL-8 production and cell migration. Elevated KDM4B expression is significantly associated with the abundance of p-c-Jun in gastric cancer and is linked to a poor clinical outcome. Together, our results suggest that KDM4B is a key regulator of JNK/c-Jun-induced processes and is a valuable therapeutic target.

Introduction

Histone lysine demethylase 4 (KDM4), which catalyzes the removal of methyl-lysine marks from histone 3, includes four members, KDM4A, KDM4B, KDM4C, and KDM4D1. The Jumonji C domain of this family shares a homologous β-jellyroll structure and a conserved active-site region that chelates α-ketoglutarate and Fe(II) for the demethylation of the repressive mark H3K9me3/me2 enrinched in heterochromatic areas2,3,4,5,6,7. Accumulating evidence implicates the overexpressions of KDM4A, KDM4B, and KDM4C in the efficient growth of human malignancies, including breast, colorectal, lung, prostate, and other tumors1. Furthermore, KDM4A and KDM4B are often amplified in gastric cancer, neuroblastoma, and ovarian cancer8,9,10,11. KDM4A regulates chromatin during DNA replication and stem cell genome reprogramming8,12. KDM4A can also interact with the co-repressor NCoR to suppress the TRAIL-DR5 pathway13 and functions as a key regulator of tumor metabolism via E2F114. KDM4B controls DNA repair and mitochondrial apoptosis, and reprograms the genomes of somatic cells of cloned embryos to control arrest15,16,17. KDM4C regulates pluripotency and embryonic development18,19. KDM4A-4C act as coactivators of androgen receptor and estrogen receptor, which are promising epigenetic drug targets5,20,21,22,23. Although these enzymes share a homologous catalytic JmjC domain, recent evidence suggests non-redundant roles of individual members in regulating distinct transcription programs24,25.

Interleukin-8 (IL-8), a chemokine acquired in the tumor microenvironment, recruits suppressive immune cells (myeloid-derived suppressor cells) and may induce epithelial-to-mesenchymal transition (EMT) via autocrine and paracrine mechanisms26,27,28,29. Notably, an elevated level of IL-8 in gastric cancer is correlated with tumor migration, invasion, and chemosensitivity30,31. Substantial increases in IL-8 can be triggered by LPS, cytokines, hypoxia, pathogens, and other environmental stresses, and these increases are mediated by transcription factors, including NF-κB and activator protein 1 (AP-1)29,32. In the presence of the prominent stomach pathogen Helicobacter pylori, NF-κB and AP-1 are translocated into the nucleus, followed by the recruitment of CREB-binding protein/P300 for the synergistic transactivation of IL-832,33. Notably, H. pylori strains that carry the cagA pathogenicity island encoding the type IV secretion system and an oncoprotein (CagA) are associated with more severe clinical sequelae34,35. Translocated CagA perturbs host signaling pathways, leading to inflammation, altered physiology, and genetic/epigenetic changes, and prompting the neoplastic transformation of gastric epithelial cells36,37. Infection with CagA-positive H. pylori is associated with the highly upregulated expression of IL-8 in a cholesterol-dependent manner38,39,40. However, little is known about the mechanism of initial removal of the repressive histone mark by epigenetic modifiers.

In this study, we examined whether IL-8 production is controlled by a KDM4 member. We showed that KDM4B, rather than KDM4A/KDM4C, significantly activated the production of IL-8 at the transcriptional level in the absence or presence of H. pylori challenge. We demonstrate that KDM4B is a coactivator of c-Jun to regulate the expressions of IL-8, MMP1, and integrin αV. The silencing of KDM4B or pharmacological inhibition of c-Jun strongly inhibits the production of IL-8. Thus, our results reveal a novel function of KDM4B in controlling the JNK/c-Jun-induced IL-8-IL-8R axis in gastric cancer, and offer a new strategy in cancer therapy.

Materials and methods

Bacteria and cell culture

H. pylori 26695 (ATCC 700392) was used as the reference strain in this study. H. pylori was routinely cultured on brucella agar plates contained with 2.8% Brucella powder (Becton Dickinson, Franklin Lakes, NJ, USA), 0.2% β-cyclodextrin (Sigma-Aldrich, St. Louis, Missouri, USA), 0.1% yeast extract, 1.5% agar (Cleveland, OH, USA), 1% isovitalex (Becton Dickinson, Franklin Lakes, NJ, USA), and 10% sheep blood in a microaerophilic atmosphere (5% O2, 10% CO2, and 85% N2) at 37 °C for 2 days. The isogenic H. pylori mutant cagA knockout strain (∆CagA) was constructed as described41. AGS cells (ATCC number: CRL-1739), the human gastric adenocarcinoma cell line, were cultured in Ham’s F-12K medium (Thermo, Waltham, MA, USA) contained with 10% fetal bovine serum (Hyclone, Logan, UT, USA) at 37 °C in 5% CO2. MKN45 cells (JCRB number: JCRB0254), the human gastric adenocarcinoma cell line, were cultured in RPMI 1640 medium (Thermo, Waltham, MA, USA) contained with 10% fetal bovine serum. 293T cells (ATCC number: CRL-3216), the human embryonic kidney cell line, were cultured in DMEM medium (Thermo, Waltham, MA, USA) contained with 10% fetal bovine serum.


Antibodies and reagents

Rabbit anti-KDM4A, anti-ERK1/2, anti-p-ERK1/2 (T202/Y204), anti-c-Jun, and anti-p-c-Jun (S63) were purchased from Cell Signaling Technology (Danvers, MA, USA). Rabbit anti-KDM4B was purchased from Bethyl Laboratories (Montgomery, TX, USA). Rabbit anti-KDM4C was purchased from Novus Biological (Littleton, CO, USA). Rabbit anti-H3K9me3 was purchased from Active Motif (Carlsbad, CA, USA). Rabbit anti-IgG, and anti-p-Tyrosine were purchased from Millipore (Billerica, MA, USA). Mouse anti-CagA, and anti-IgG were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Mouse anti-β-Actin was purchased from Sigma. Lentiviral vector pLKO-control (pLKO), pLKO-shKDM4A (sh4A#1, TRCN0000234912; sh4A#2, TRCN0000234914), -shKDM4B (sh4B#1, TRCN0000018016; sh4B#2, TRCN0000379460), -shKDM4C (sh4C#1, TRCN0000235047; sh4C#2, TRCN0000235048) plasmids were purchased from The RNAi Consortium (TRC).


Establishment of KDM4B-knockdown cells

Lentivirus particles were produced in 293T cells using pLP1, pLP2, and pLP/VSVG packaging system (Thermo, Waltham, MA, USA) according to the user’s manual. KDM4-knockdown cell lines were established in AGS and MKN45 cells using pLKO, sh4A, sh4B, and sh4C lentivirus infection, and cells were then selected with puromycin (2 μg/ml for AGS and 5 μg/ml for MKN45) for 1 week. Knockdown efficiency was confirmed using qRT-PCR and/or immunoblotting analysis.


Human cytokine array

The supernatants of pLKO and sh4B#1 AGS cells infected with H. pylori at an moi of 50 for 6 h were collected. Human cytokine array Panel A (R&D Systems, Minneapolis, MN, USA) was used to detect cytokines in the supernatants according to the manufacturer’s instructions.


Quantitative real-time PCR (qRT-PCR)

Total RNAs were extracted with TRIzol reagent (Thermo) and the cDNAs were prepared using the SuperScript III Reverse Transcriptase (Thermo), dNTP (Genedirex, Las Vegas City, NV, USA), and random primers (Thermo). The amount of cDNA was detected with SensiMix™ SYBR® Hi-ROX Kit (Bioline, Taunton, MA, USA) and primers (listed in Table S3) with ABI StepOnePlus Real-Time PCR System (Thermo). All data were triplicated, and normalized to GAPDH.


Human IL-8 ELISA

AGS cells were infected with H. pylori at an moi of 50 for 6 h, and MKN45 cells were infected at an moi of 50 for 3 h. Supernatants were collected to detect IL-8 production by using Human IL-8 Cytoset Kit (Thermo).


Cell elongated hummingbird phenotype

AGS cells (2×105) were cultured in 6-well plates and then infected with wild-type H. pylori at an moi of 50 for 6 h as previously described39. Cells were examined with a Zeiss Axio Observer inverted microscope (Carl Zeiss, Jena, Germany) and images were captured and processed by the AxioVision software. The elongated phenotype was defined as cells that had thin needle-like protrusions that were > 20 μm long and had needle-like elongated cells39. Over 300 cells were calculated in triplicate experiments.


Immunoblotting assay

Cells were infected with H. pylori at an moi of 50. Cells were washed three times with PBS and cell pellets were collected by a scraper and lysed in RIPA buffer supplemented protease inhibitor (Santa Cruz) and PhosSTOP (Sigma). Appropriate amounts of lysates were fractionated by SDS-PAGE and then transferred onto PVDF membrane (PALL, Port Washington, NY, USA). Membrane was incubated with appropriately diluted primary antibody at 4 °C overnight and then probed with secondary antibodies conjugated with fluorescence. Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE, USA) was used to detect the level of fluorescence.


Immunoprecipitation (IP) assay

Cell pellets were collected from 80% confluent wild-type AGS cells and lysed in IP lysis buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5% NP40) supplemented with protease inhibitor (Santa Cruz). Appropriate amounts of protein samples were incubated with the corresponding antibodies (1 μg) as indicated and 10 μl of PureProteome protein A/G magnetic beads (Millipore) at 4 °C overnight. The beads were washed three times with IP-wash buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 0.1% Tween 20, pH 7.4) and eluted by the IP-lysis buffer, followed by immunoblotting assay with corresponding antibodes as indicated.


Luciferase activity assay

AGS cells were seeded onto 12-well plates overnight, and then transfected with IL-8, ∆AP-1, or ∆NF-κB luciferase reporter constructs and internal control reporter β-galactosidase using Lipofectamine 2000 (Thermo). After 16-h incubation, cells were infected with H. pylori at an moi of 50 for 6 h. The luciferase activities were determined using the Beta-Glo/One-Glo Assay System (Promega Corporation, Madison, WI, USA).


ChIP assay

AGS cells were infected with H. pylori at an moi of 50 for 3 h, and were crosslinked with 1% formaldehyde for 10 min and then quenched in 0.125 M glycine. The crosslinked chromatin was fragmented by sonication. The lysate were subjected to IP using corresponding antibodies as indicated (anti-KDM4B, anti-c-Jun, anti-H3K9me3, and rabbit IgG) and Magna ChIP Protein G Magnetic beads (Millipore) at 4 °C overnight. The ChIP complexes were eluted by elution buffer [50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 1% SDS] and quantified by qRT-PCR (primer sequences listed in Table S3). Fold enrichment was calculated by the ∆∆Ct method.


Small interfering RNA (siRNA) transfection

To downregulate the expression of ITGAV and ITGB1, transfection of specific si-RNA (Dharmacon, Lafayette, CO, USA) was performed by using Lipofectamine 2000 according to the manufacturer’s protocol. Expression of ITGAV and ITGB1 was evaluated using qRT-PCR. si-RNA sequences listed in Table S4.


Microarray

Global expression analysis was performed in AGS cells (pLKO vs. sh4B#1) non-infected or infected by H. pylori at an moi of 50 for 6 h (GEO: GSE107703). Microarray analysis was conducted by the National Health Research Institutes, using Affymetrix GeneChip Human Gene 2.0 ST Array (Affymetrix, Santa Clara, CA, USA). Subsequent data analysis was done by DAVID Bioinformatics database. AP-1 and NF-κB binding genes were analyzed by UCSC genome browser tool (http://www.genome.ucsc.edu/).


Micro-western array (MWA)

Cytokine production analysis in non-infected and H. pylori-infected AGS cells (pLKO vs. sh4B#1) was performed by the MWA Core facility of the National Health Research Institutes, using appropriate antibodies as indicated and followed the MWA protocol previously described42.


Wound healing assay

AGS cells were seeded onto 6-well plates overnight. A linear wound was generated by scratching a 10-μl pipette tip onto cells, followed by three washes of PBS to remove the detached cells. Cells were then non-infected or infected with H. pylori at an moi of 50. The wound closure was monitored with a Leica microscopy (Leica, Wetzlar, Germany) at indicated time points. The percentage of wound closure was quantified by ImageJ.


Immunohistochemistry (IHC)

Two consecutive paraffin-embedded human gastric cancer biopsies (n = 87) containing paired tumor and adjacent normal tissue were obtained from Chang Gung Memorial Hospital, Taoyuan, Taiwan. IHC staining was performed using anti-KDM4B and anti-p-c-Jun. IHC data for KDM4B and p-c-Jun staining was graded into positive and negative categories based on the presence of strong nuclear staining or not. This study is approved by Institutional Review Board of Chang Gung Memorial Hospital.


Kaplan–Meier plotter survival analysis

Overall survival and first progression were analyzed using KM Plotter online tool (http://kmplot.com/analysis/) in which the database consists of 1065 gastric cancer patients43. Datasets used to examine the relationship with KDM4B expression include 212492_s_at, 215616_s_at, 216023_at, and 212495_at and those with IL-8 expression are 211506_s_at and 202859_x_at.


Statistical analysis

The Student’s t-test was used to calculate the statistical significance of the experimental results between two groups (significance at p < 0.05). All values reflect mean ± SD of data obtained from at least three independent experiments. Chi-square test was performed to compare groups with categorical variables in IHC analysis.

Results

KDM4B, but not KDM4A/KDM4C, upregulated IL-8 production, particularly upon H. pylori infection

It is now well recognized that histone modifications are crucial platforms in modulating chromatin conformation and gene transcription. Among the histone demethylases, KDM4 family plays a major role in transcriptional activation1,44. We hypothesized that a KDM4 family member regulates the production of IL-8. To test this notion, AGS cells, a gastric cancer cell line, were transduced with control (pLKO) or two independent knockdown constructs (sh4A#1, sh4A#2, sh4B#1, sh4B#2, sh4C#1, and sh4C#2) based on the lentivirus approach to deplete endogenous KDM4A, KDM4B, and KDM4C, respectively (Fig. 1a). Upon H. pylori (strain 26695) infection, pLKO cells displayed significantly higher production of IL-8 than did non-infected cells (28.2-fold, p < 0.05), consistent with previous results indicating that H. pylori stimulates IL-8 production in AGS cells39. Of KDM4-knockdown lines, a significantly reduced signal of IL-8 was detected for two KDM4B-knockdown lines, but not for KDM4A- or KDM4C-knockdown lines without H. pylori infection (Fig. 1b, p < 0.01). With H. pylori infection, KDM4B-knockdown, but not KDM4A-/KDM4C-knockdown lines, again showed significantly lower IL-8 production than did the infected pLKO control cells (p < 0.01). To test whether KDM4B serves as a general regulator of IL-8 production for gastric cancer cells infected with H. pylori, we compared the production of IL-8 in various gastric cancer lines including AGS, MKN28, MKN45, and SNU601. Figure S1A shows that all cell lines had an increased level of IL-8 production upon H. pylori infection. Analysis of KDM4B expression revealed that MKN45 had a comparable level with that of AGS (Figure S1B). We thus further evaluated whether the depletion of KDM4B in MKN45 affected the production of IL-8. Upon H. pylori infection, KDM4B-knockdown MKN45 cells indeed led to a significantly reduced level of IL-8 production, suggesting that KDM4B as an important regulator of IL-8 expression in gastric cancer cells (Figure S1C‒1D).

Fig. 1: Silencing of KDM4B but not KDM4A/KDM4C inhibits the production of IL-8.
Fig. 1

a Generation of KDM4A-, KDM4B-, and KDM4C-knockdown AGS cells. Cells were infected with lentivirus using a control shRNA (pLKO) and two independent short-hairpin constructs to generate shKDM4A (sh4A#1 and sh4A#2), shKDM4B (sh4B#1 and sh4B#2), and shKDM4C (sh4C#1 and sh4C#2), respectively. Depletion of KDM4A, KDM4B, or KDM4C was confirmed by western blotting analysis. β-Actin was the internal control. b IL-8 release was measured from the supernatants of non-infected or H. pylori-infected cells by ELISA. Data represent the mean ± standard deviation (SD) from three independent experiments. c Images of cytokine arrays for the detection of the relative levels of cytokines from supernatants of pLKO and sh4B#1 cells, respectively. Cells were non-infected (−Hp) or infected with H. pylori (+ Hp) at an moi of 50 for 6 h. d The relative fold of IL-8, CXCL1, and CCL5 was measured and shown as a ratio of pLKO (−Hp) levels from (c). *p < 0.05; **p < 0.01

We next examined the expression levels of 37 cytokines in cell culture supernatants of KDM4B-knockdown and pLKO cells uninfected or infected with H. pylori. The levels of IL-8, CCL5, and CXCL1 were significantly downregulated in uninfected KDM4B-knockdown cells. Infection with H. pylori further stimulated the production of these cytokines. Notably, IL-8 was the most highly upregulated cytokine (30.6-fold) (Fig. 1c, d). These results suggest that KDM4B is a key epigenetic regulator of IL-8 production, and its effects are even more pronounced upon H. pylori infection.

KDM4B regulates the expression of NF-κB and AP-1 target genes

To characterize the molecular mechanisms by which IL-8 is upregulated in response to KDM4B, differential gene expression between pLKO and KDM4B-knockdown AGS cells was examined by microarray analysis (≥ 2-fold alterations) (GEO: GSE107703). Functional annotations indicated that a number of downregulated genes in uninfected cells were involved in the following functions: response to stimulus, virus, wounding, chemical stimulus, and multi-organism process (Figure S2A). Infection with H. pylori revealed the following categories of differentially expressed genes: response to virus, multi-organism process, and response to stimulus. Interestingly, a substantial proportion of downregulated genes (144/300 = 48%) in the non-infected set were also observed in the infected set (Figure S2B). We surveyed whether these genes share the NF-κB and AP-1 binding motifs using the tool provided by the UCSC Genome Browser. Of these genes (n = 144), a high fraction (38.2%) showed AP-1 or NF-κB-binding motifs, i.e., 31 had an AP-1-binding site, 18 had an NF-κB-binding element, and 6 (including IL-8 and MMP1) carried both motifs (Figure S2C).

JNK/c-Jun signaling is crucial for KDM4B-mediated IL-8 production

To characterize the signaling pathways involved in KDM4B-mediated IL-8 production, we compared protein abundance and modifications using a western microarray with 59 antibodies (phosphosites) against proteins in four signaling pathways (JNK, ERK, p38, and PI3K). Infected pLKO cells showed stimulated signaling in the four pathways as compared with the levels in non-infected pLKO cells38,45,46,47. For KDM4B-knockdown cells, interestingly, non-infected cells had greatly decreased signals for the JNK (p-JNK and p-c-Jun) and ERK (p-MEK1 and p-ERK1/2) pathways as compared with those of control cells particularly the JNK pathway. The p38 and PI3K pathways exhibited inconsistent and relatively little differences between KDM4B-knockdown and control cells without H. pylori infection. Upon H. pylori infection, ERK and JNK signaling were only slightly induced in KDM4B-knockdown cells, whereas the p38 and PI3K pathways were essentially unchanged in comparison with the levels (Fig. 2a). The increased level of p-c-Jun was confirmed in infected pLKO cells, but much less in KDM4B-knockdown cells at 60 min and 120 min post-infection by western blotting (Fig. 2b). Treatment with a specific JNK inhibitor SP600125 that blocks the phosphorylation of c-Jun48 significantly reduced the expression of IL-8 in response to H. pylori stimulation in AGS cells (Fig. 2c, d) and in MKN45 cells (Figure S3A). Fig. 2e and Figure S3B show that SP600125-treated cells (0–25 μM) exhibited a reduced signal of p-c-Jun and a slightly reduced expression of KDM4B in a dose-dependent manner. These results together suggest that the JNK pathway contributes to KDM4B-mediated IL-8 production.

Fig. 2: Silencing of KDM4B reduced the JNK/c-Jun and ERK signaling.
Fig. 2

a Micro-Western Array heat-map chart shows the abundance and phosphorylation signal protein fold change of non-infected or H. pylori-infected sh4B#1 cells as compared to pLKO control cells. β-Actin was the internal control. b The expression of c-Jun and phosphorylation of c-Jun in non-infected or H. pylori-infected pLKO, sh4B#1, and sh4B#2 cells were detected by immunoblotting. c AGS cells were untreated or treated with SP600125 (25 μM) in the absence (−Hp) or presence of H. pylori (+ Hp) at an moi of 50 for 6 h. c-Jun, p-c-Jun, and β-actin were detected by immunoblotting. d IL-8 mRNA levels were measured from AGS cells untreated or treated with SP600125 according to (c). e AGS cells were treated with indicated concentrations of SP600125, followed by immunoblotting analysis with anti-KDM4B, anti-p-c-Jun, anti-c-Jun, and β-actin antibodies, respectively. *p < 0.05; **p < 0.01

KDM4B interacts with c-Jun and regulates IL-8 promoter activity

Since the expression of IL-8 is regulated by both NF-κB and AP-133, we evaluated whether KDM4B cooperates with NF-κB and/or AP-1 using an IL-8 reporter plasmid in which the promoter region consists of AP-1 and NF-κB sites fused with a luciferase reporter gene (IL-8-luc)49. Depletion of KDM4B significantly attenuated the transactivation of IL-8 promoter activity. We then compared the contribution of AP-1 or NF-κB to IL-8 reporter activity using two mutant reporter plasmids (∆AP-1 carrying a deleted AP-1-binding motif and ∆NF-κB carrying a deleted NF-κB-binding motif). The introduction of ∆AP-1 into control cells markedly reduced the transactivation activity (23% residual activity) as compared with the 83% residual activity observed using ∆NF-κB. Depletion of KDM4B significantly reduced IL-8 transactivation activity for both mutant vectors. Notably, only minor activity was detected for the KDM4B-knockdown cells transfected with ∆AP-1 (Fig. 3a). These results together suggest that KDM4B cooperates with NF-κB and AP-1 to regulate IL-8 expression by removing the repressive H3K9me3 and thereby relaxing the heterochromatin. In support of this notion, Han et al.10 found that KDM4B interacts with NF-κB (p65) to drive the expression of Cox2.

Fig. 3: KDM4B interacts with c-Jun and regulates IL-8 promoter activity.
Fig. 3

a The IL-8 promoter activity of cells (pLKO, sh4B#1, or sh4B#2) cotransfected with IL-8-luc, ∆AP-1, or ∆NF-κB plus β-galactosidase (an internal control). b Endogenous association of KDM4B and c-Jun. AGS cell lysates were used for KDM4B and c-Jun IP, respectively. The input and IP were detected by anti-KDM4B or anti-c-Jun antisera. Rabbit IgG was used as a negative control. c AGS cells were cotransfected with Flag-c-Jun and a series of N-terminal or C-terminal HA-KDM4B mutants, followed by IP using anti-Flag. d KDM4B was upregulated in the presence of H. pylori. KDM4B was detected by anti-KDM4B antibody. β-actin was an internal control. e The depletion of KDM4B reduced the IL-8 promoter activity. Cells (pLKO, sh4B#1, or sh4B#2) were cotransfected with IL-8-luc plus β-galactosidase in the absence (−Hp) or presence (+ Hp) of H. pylori. f The IL-8 promoter activity of KDM4B-knockdown cells (sh4B#1 or sh4B#2) was restored by introduction of a shRNA-resistant KDM4B expression vector. KDM4Ba and KDM4Bb: the #1 and #2 shRNA-resistant KDM4B vectors, respectively. g Introduction of the inactive KDM4B mutant, KDM4BH189A, displayed a lower level of the IL-8 promoter activity than that of the wild-type KDM4B in AGS cells. The IL-8 promoter activity was measured from AGS cells cotransfected with wild-type KDM4B (KDM4BWT) or inactive mutant (KDM4BH189A) in the absence (−Hp) or presence (+Hp) of H. pylori. The relative activity was normalized to that of mock vector-transfected cells. *p < 0.05; **p < 0.01

We thus asked whether KDM4B interacts with AP-1. Immunoprecipitation (IP) of lysates using anti-KDM4B antibodies from AGS cells showed that endogenous KDM4B interacts with c-Jun, a crucial component of AP-1. A reciprocal IP of lysates using c-Jun also detected endogenous KDM4B, suggesting that KDM4B is associated with c-Jun (Fig. 3b) and thereby interacting with AP-1. We next examined the minimal region of KDM4B crucial to interact with c-Jun using a series of N-terminal and C-terminal HA-tagged KDM4B mutants (∆N470, ∆C180, ∆C290, and ∆C460) (Fig. 3c). AGS cells were cotransfected with Flag-c-Jun plus each of the truncated HA-KDM4B clones, followed by IP and western blotting analysis. KDM4BΔC180 retained comparable association with c-Jun. KDM4BΔC290 and KDM4BΔC460 had a decreased level of association, whereas much weaker signal was detected for KDM4BΔN470 (Fig. 3c). These results revealed that N-terminal region of KDM4B that consists of the JmjN-JmjC-PHD region (residues 1–907) is important for interacting with c-Jun. Interestingly, infection with H. pylori induced an increase in KDM4B production (Fig. 3d). This increase was accompanied by an increased IL-8 reporter activity upon H. pylori infection. Depletion of KDM4B significantly reduced the promoter activity, irrespective of H. pylori infection (Fig. 3e).

We next tested whether the restoration of KDM4B expression in KDM4B-knockdown cells could rescue IL-8 promoter activity. Figure 3f shows that the introduction of a shRNA#1-resistant KDM4B expression clone, KDM4Ba, into the sh4B#1 line significantly restored transactivation activity, without and with H. pylori infection. Likewise, IL-8 reporter activity for sh4B#2 could be rescued by introducing a shRNA#2-resistant KDM4B expression clone, KDM4Bb. We also measured the release of IL-8 when KDM4B expression was restored in KDM4B-knockdown cells by using the same constructs. As seen in Figs. S4A-4B, a significantly elevated level of IL-8 production was detected in H. pylori-infected KDM4B-knockdown AGS cells and MKN45 cells. On the other hand, the introduction of an inactive mutant vector H189A into AGS cells significantly reduced IL-8 reporter activity as compared with that of the WT KDM4B vector without or with H. pylori infection (Fig. 3g). Thus, KDM4B is a crucial regulator of IL-8 transactivation via its demethylase activity. Its physical interaction with the AP-1 component c-Jun might contribute to the regulation of the IL-8 transactivation activity.

KDM4B and c-Jun are co-recruited to the AP-1 site of the IL-8 and MMP1 loci

We next determined whether KDM4B and c-Jun were co-recruited to the same target loci using a ChIP analysis with anti-KDM4B, anti-c-Jun, and anti-H3K9me3 antibodies. We showed that the depletion of KDM4B significantly reduced the occupancy of KDM4B and c-Jun (LKO vs. sh4B#1/sh4B#2) on the IL-8 promoter region in non-infected cells (Fig. 4a, b). Infection with H. pylori significantly increased the occupancy of KDM4B and c-Jun. Conversely, the depletion of KDM4B (sh4B#1 or sh4B#2) essentially blocked the occupancy of c-Jun. In parallel, there was a significantly increased level of the repressive H3K9me3 mark on this locus (Fig. 4c), consistent with the reduced promoter activity of IL-8 observed in KDM4B-knockdown cells (Fig. 3e).

Fig. 4: KDM4B enhances the recruitment of c-Jun to the IL-8 and MMP1 promoters.
Fig. 4

ChIP analysis of KDM4B and c-Jun occupancy and H3K9me3 signal on the promoter of IL-8 (ac) or MMP1 (df) in non-infected AGS cells or those infected with H. pylori. Chromatin immunoprecipitation (ChIP) was performed with specific antibodies against KDM4B (a, d), c-Jun (b, e), and H3K9me3 (c, f), respectively. AGS cells were infected with H. pylori at an moi of 50 for 3 h, followed by ChIP analysis. Fold enrichments normalized to IgG are presented (mean ± SD from three independent experiments). *p < 0.05; **p < 0.01

A similar trend was found in the ChIP analysis of the MMP1 locus. Infection with H. pylori significantly increased the occupancy of KDM4B and c-Jun, and significantly decreased the H3K9me3 signal (Fig. 4d‒f). Conversely, the depletion of KDM4B led to a significantly reduced level of c-Jun occupancy (Fig. 4e), but an elevated level of H3K9me3 (Fig. 4f). These results together suggest that KDM4B affected the enrichment of c-Jun on the relevant promoters, and this effect was more pronounced in the presence of H. pylori challenge, hence promoting c-Jun transactivation.

Silencing of KDM4B reduces type IV secretion system-mediated CagA signaling in H. pylori-infected cells

The key virulence factor CagA can be translocated and become phosphorylated, inducing aberrant cell signaling and the substantial upregulation of IL-838,40. We asked whether KDM4B was involved in CagA-mediated IL-8 production. As shown in Fig. 5a, IL-8 production was significantly lower in KDM4B-knockdown cells infected with either WT or ∆cagA (Fig. 5a). Significantly upregulated production of IL-8 was only seen in control cells infected with WT H. pylori. We next compared the levels of translocated/phosphorylated CagA in control (pLKO) vs. KDM4B-knockdown cells infected with H. pylori. Infection of KDM4B-knockdown cells with WT H. pylori greatly reduced the levels of phosphorylated CagA as compared with those of uninfected control cells, suggesting that KDM4B is crucial for the translocation of CagA into infected cells (Fig. 5b).

Fig. 5: H. pylori CagA is essential for KDM4B-mediated IL-8 production and hummingbird phenotype formation in infected cells.
Fig. 5

a The CagA-positive H. pylori-induced IL-8 production mediated by KDM4B was significantly reduced in ∆cagA-infected AGS cells. Control and KDM4B-knockdown cells (sh4B#1 and sh4B#2) were either not infected or infected with WT (strain 26695) or ∆cagA at an moi of 50. IL-8 released into the culture supernatant was measured by ELISA. The values are means and SDs of three independent experiments. Statistical significance was evaluated using the Student’s t-test (*p < 0.05; **p < 0.01). b Detection of translocated phosphorylated CagA in KDM4B-knockdown cells was reduced. AGS cells were infected with WT or ∆cagA H. pylori at an moi of 50 for 6 h. Phospho-tyrosine antibody was used for determining phospho-CagA (p-CgaA) in immunoblotting assay. c Infection of KDM4B-knockdown cells with WT H. pylori had significantly reduced ability to display the hummingbird phenotype as compared with the control AGS cells. AGS cells were either not infected (−Hp) or infected with strain 26695 (+ Hp) at an moi of 50 for 3 h. Cells were visualized by phase-contrast microscopy to assess AGS cell morphology. Scale bar, 20 μm. d Quantification of the percentage of elongated cells from (c). e Infection of KDM4B-knockdown cells with WT H. pylori reduced cell migration. Wound healing effect of control (pLKO) and KDM4B-knockdown (sh4B#1 and sh4B#2) AGS cells at indicated post-infection time points. f The percentage of wound closure was measured from (e). The values are means and SDs of three independent experiments. Statistical significance was evaluated using the Student’s t-test. *p < 0.05; **p < 0.01

We also evaluated the formation of an elongated cell, referred to as a hummingbird phenotype that is p-CagA-dependent in cells without or with H. pylori infection50,51. Figure 5c, d shows that infected KDM4B-knockdown cells displayed a significantly reduced level of the hummingbird phenotype (p < 0.01). Additionally, we determined whether the knockdown of KDM4B affected cell migration mediated by translocated CagA using a wound healing assay52. Infected KDM4B-depleted cells also exhibited a significantly reduced wound healing effect at 16-h post-infection (Fig. 5e, f). Thus, these results together substantiate the notion that KDM4B regulates the translocation of CagA upon H. pylori infection.

KDM4B directly regulates the expression of ITGAV encoding integrin αV to facilitate the translocation of CagA

We reasoned that the integrin protein responsible for interactions with CagL (the RGD-containing protein) on the pilus of the type IV secretion system to deliver CagA53 was regulated by KDM4B. Microarray data showed no significant differential expression of genes encoding integrin α5 and β153. Instead, another integrin member, ITGAV, encoding integrin αV was significantly downregulated in the two KDM4B-knockdown lines (sh4B#1 and sh4B#2) as compared with control cells (Fig. 6a). H. pylori-infected cells exhibited a higher level of ITGAV expression than that of non-infected cells, indicating that KDM4B regulated the expression of ITGAV.

Fig. 6: KDM4B regulates the expression of integrin αV.
Fig. 6

a Reduced expression of integrin αV encoded by ITGAV in KDM4B-knockdown cells. qRT-PCR analysis was performed to evaluate the expression of ITGAV in pLKO, sh4B#1, and sh4B#2 cells, respectively. Cells were either not infected (−Hp) or infected with strain 26695 (+ Hp) at an moi of 50 for 3 h. b, c Silencing of integrin αV and β1 reduces H. pylori-stimulated IL-8 production. AGS cells were transfected with control (si-scr), integrin αV (si-ITGAV), or β1 (si-ITGB1) siRNA and cultured for 24 h, followed by non-infection (−Hp) or infection with H. pylori (+ Hp) at an moi of 50 for 3 h. Total RNAs were prepared and subjected to qRT-PCR for ITGAV and ITGB1 expression (b). IL-8 released into the culture supernatant was measured by ELISA (c). df KDM4B is recruited at the ITGAV locus. Chromatin was prepared from pLKO, sh4B#1, or sh4B#2 cells with anti-KDM4B (d), c-Jun (e), or H3K9me3 (f), followed by quantitative PCR analysis. Fold enrichments normalized to IgG are presented. The values are means and SDs of three independent experiments. Statistical significance was evaluated using the Student’s t-test. *p < 0.05; **p < 0.01

Integrin αV is highly expressed in AGS cells53 and interacts with integrin β1 to form a heterodimer that binds to RGD-containing proteins54. We tested whether αVβ1 mediates IL-8 production in H. pylori-infected cells. AGS cells treated with si-scr treatment, when non-infected, had a low signal of IL-8 production (Fig. 6c) as compared with a slightly higher level of IL-8 production in non-infected pLKO cells (Fig. 1b). We speculate that the variation of IL-8 release stemmed from different approaches utilized; while the pLKO control was a stable line derived based on the delivery of pLKO-shRNA, si-scr control was conducted by introduction of AGS with si-scr under a transient transfection condition. Despite slight difference in the level of IL-8, they represent a relatively small value (<5%) as compared with those in infected cells. Depletion of ITGAV by siRNA (si-ITGAV), interestingly, led to a significantly lower level of IL-8 production in cells infected with H. pylori as compared with scramble siRNA (si-scr)-treated cells (Fig. 6b, c). A comparable result was also obtained for cells depleted of integrin β1 (si-ITGB1). Similar effects were also found for MKN45 cells (Figure S3C), together suggesting that the expression of IL-8 and ITGAV was regulated by KDM4B and could be stimulated by H. pylori challenge.

We further asked whether KDM4B and c-Jun were co-recruited to the promoter region of ITGAV using a ChIP analysis. Depletion of KDM4B (sh4B#1 and sh4B#2) significantly reduced the occupancy of KDM4B and c-Jun at the ITGAV locus (Fig. 6d, e). Infection with H. pylori significantly increased the recruitment of both KDM4B (p < 0.01) and c-Jun (p < 0.05) as compared with that in non-infected control cells. Conversely, a significantly reduced level of KDM4B and c-Jun on the ITGAV locus (p < 0.01) was seen for infected KDM4B-knockdown cells as compared with the infected control cells. Furthermore, there was a significant increase of the repressive H3K9me3 mark at this locus (Fig. 6f), indicating that KDM4B contributes to demethylation activity. Taken together, these results suggest that KDM4B and c-Jun regulate the expression of ITGAV, which encodes integrin αV, to facilitate the translocation of CagA upon H. pylori infection, at least in part.

KDM4B expression and p-c-Jun abundance are positively correlated in gastric cancer

KDM4B overexpression is associated with tumor growth in gastric cancer55. To further determine the clinical relevance of KDM4B and p-c-Jun in gastric cancer, we examined the expression of KDM4B and the abundance of p-c-Jun in two consecutive sections of paraffin-embedded gastric cancer specimens (total, n = 87; intestinal, n = 18; diffuse-type, n = 28; mix, n = 11; unknown, n = 30) by immunohistochemistry. Forty out of 87 showed positive KDM4B staining in tumor tissue nuclei, but no signal in normal tumor-adjacent regions (Fig. 7a). The nuclear signal of p-c-Jun was clearly visible in the tumor region of 53 subjects in the cancerous region, and no signal was observed in the normal tumor-adjacent region. The expression of KDM4B was significantly positively correlated with the abundance of p-c-Jun (p = 0.041, Fig. 7b). We then evaluated the clinical relevance of co-expression of both KDM4B and p-c-Jun using Kaplan–Meier analysis. Strikingly, the co-expressed KDM4B-p-c-Jun group was significantly associated with a low overall survival rate among patients with advanced T stage (T2–T4; n = 67) as compared with only one or no expression of both markers (Fig. 7c).

Fig. 7: Elevated expression of KDM4B and the abundance of p-c-Jun are clinically associated in gastric cancer.
Fig. 7

a Immunohistochemical detection of KDM4B and p-c-Jun in gastric tissue specimens. The expression level of KDM4B and the signal of p-c-Jun in gastric tissue specimens are elevated in the cancerous site as compared with the adjacent normal site. b The correlation between KDM4B expression and p-c-Jun signal in 87 gastric cancer biopsies. Statistical significance was evaluated using the Chi-square test. c Overall survival of GC patients with co-expression of KDM4B and p-c-Jun in advanced gastric cancer biopsies defined by the Kaplan–Meier curves. Overall survival of patients with advanced T stage (T2−T4; n = 67) were assessed. +, positive expression in both KDM4B and p-c-Jun; –, negative expression in one of KDM4B and p-c-Jun or none. d Kaplan–Meier survival curves. KM plots of gastric cancer survival for patients with KDM4B and IL-8 expression

We next used the Kaplan–Meier (KM) approach (KM Plotter: http://kmplot.com) to analyze gene expression in patients with gastric cancer with respect to the endpoints of overall survival (OS, n = 876) and first progression (FP, n = 641)43. A KM plotter analysis revealed that elevated expression of KDM4B was significantly associated with worse OS and FP outcomes (Affy ID: 212495_at, 212492_s_at, 215616_s_at, 216023_at) (Fig. 7d and Table S1). When patients were classified into cohorts based on Lauren histological subtypes, both the intestinal and diffuse types carrying elevated expression of KDM4B had worse OS and FP. Furthermore, high expression of IL-8 was associated with a worse clinical outcome in all-type gastric cancer as well as in intestinal- and in diffuse-type gastric cancer (Fig. 7d and Table S2). These results suggest that elevated KDM4B expression is significantly associated with the abundance of p-c-Jun, which is a major stress-activated protein, thus regulating the IL-8 expression in gastric cancer and being linked to a poor clinical outcome.

Discussion

KDM4A and KDM4B are considered promising therapeutic targets for prostate and breast tumor growth based on their functions as coactivators of androgen receptor and estrogen receptor, respectively1,5,23. KDM4A recruits E2F1 to control cancer metabolism for proficient prostate cancer growth14. Here, we show that the silencing of KDM4B, but not KDM4A/KDM4C, with specific shRNAs significantly reduced IL-8 production in gastric cancer cells. This effect was significantly triggered in cells stressed by H. pylori infection, indicating an exclusive pathogenic function. IL-8 is well documented for its ability to activate inflammation-mediated processes and angiogenesis in a variety of cancers, including prostate and gastric cancers56,57. Elevated expression of IL-8 also induces proliferation and migration and is correlated with a poor prognosis in gastric cancer58. In this study, we provide evidence that KDM4B functions as a novel coactivator of c-Jun to mediate AP-1-controlled genes, including IL-8 and MMP1, based on several lines of evidence: (i) Microarray data show the significant differential expression (i.e., downregulation) of c-Jun targets in response to stimuli between LKO control and KDM4B-knockdown cells. (ii) KDM4B physically interacts with c-Jun. (iii) KDM4B and c-Jun are co-recruited to IL-8, MMP1, and ITGAV promoters. (iv) The depletion of KDM4B significantly reduces the IL-8 production and occupancy of c-Jun, but increases H3K9me3 at the promoter region of IL-8 and MMP1. Although KDM4A and KDM4B share a highly conserved JmjC domain and similar primary-structure organization, their C-terminal PHD and Tudor domains are less homologous (sequence identity, ~50%)2,3. Recent evidence shows that they display an overlapping, but distinct spatiotemporal expression profile, allowing them to function individually and combinatorially to control specific subsets of gene targets24,25. Notably, KDM4B but not KDM4A is a hypoxia-inducible epigenetic factor59,60, despite that they often exhibit elevated expression in gastric cancer (Figure S5). Furthermore, KDM4B is induced by H. pylori challenge, but inhibited by a JNK inhibitor, suggesting that it has a unique role under stress conditions. Taken together, our results suggest that KDM4B recruits c-Jun and promotes IL-8 production via JNK/c-Jun signaling, possibly involving a positive feed-forward loop under stress-associated conditions in gastric cancer (Figure S6).

We demonstrate that KDM4B and c-Jun regulate CagA-dependent signaling via integrin αV, a RGD-binding receptor61, upon H. pylori infection. Previously, the initial contact point between H. pylori and epithelial cells has been identified as the bacterial pilus adhesion molecule CagL carrying the RGD motif and the host integrin α5β1, which leads to subsequent CagA delivery by the type IV secretion system to propagate the CagA cascade, activating AP-1 (c-Jun and c-Fos) and inducing IL-8 secretion45,53,62. We show that integrin αV could also contribute to this effect, at least in part. First, the knockdown of KDM4B resulted in decreased ITGAV expression and a reduced occupancy of KDM4B on the ITGAV promoter. Second, CagA phosphorylation was significantly reduced in KDM4B-knockdown-infected cells as compared with infected control cells. Third, knocking down the expression of ITGAV significantly reduced the IL-8 production induced by H. pylori. Interestingly, infection with H. pylori induced the expression of both KDM4B and ITGAV, thereby augmenting the propagation of CagA signaling, phosphorylation of c-Jun, and activation of IL-8 expression via the KDM4B-c-Jun complex upon H. pylori infection.

KDM4B is overexpressed in gastric tissues, and plays an oncogenic role in gastric carcinogenesis56. Of note, the tumor suppressor miR-491-5p shows a reduced expression in gastric tissues and blocks cell proliferation and survival55,63. KDM4B interacts with NF-κB (p65) and regulates the expression of Cox-2, an isoform of cyclooxygenase involved in angiogenesis, in H. pylori-infected AGS cells10. We show that the infection of KDM4B-knockdown cells led to the reduced production of IL-8 as well as CXCL1 and CCL5, which are chemokines involved in gastric cancer progression64,65. We further demonstrate that KDM4B recruited c-Jun for efficient transcriptional activation of IL-8 in a demethylase-dependent manner. While H. pylori-infected cells triggered both ERK and JNK signaling, which can stimulate IL-8 production, deletion of the AP-1 site drastically reduced IL-8 transactivation activity as compared with that observed for the deletion of the NF-κB-binding motif in KDM4B-knockdown infected cells. Immunohistochemistry analysis of gastric cancer biopsy specimens revealed that elevated KDM4B expression was significantly associated with the abundance of p-c-Jun in cancerous tissues. Notably, those advanced T-stage patients bearing positive expression of both KDM4B and p-c-Jun harbor a worse survival rate, suggesting co-expression of KDM4B and p-c-Jun as a potential prognostic marker. Furthermore, the overexpressions of KDM4B and IL-8 are linked to a poor overall survival. Of note, KDM4B is associated with chromosomal instability in breast cancer; the overexpression of exogenous KDM4B leads to the loss of centromere-associated H3K9me3 and elevated chromosomal instability66. Although the initiation and progression of such a functional KDM4B-c-Jun loop in gastric carcinogenesis requires more elaborate mechanistic elucidation, we propose that KDM4B, an inducible epigenetic factor under stress conditions, contributes to the deregulation of the paracrine/autocrine gastric microenvironment and angiogenesis. Targeting KDM4B, a coactivator of c-Jun and NF-κB, is a potential new strategy for effective therapeutic intervention in gastric cancer progression.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by G. Ciliberto

References

  1. 1.

    Berry, W. L. & Janknecht, R. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res. 73, 2936–2942 (2013).

  2. 2.

    Chen, Z. et al. Structural insights into histone demethylation by JMJD2 family members. Cell 125, 691–702 (2006).

  3. 3.

    Hillringhaus, L. et al. Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family. J. Biol. Chem. 286, 41616–41625 (2011).

  4. 4.

    Krishnan, S. & Trievel, R. C. Structural and functional analysis of JMJD2D reveals molecular basis for site-specific demethylation among JMJD2 demethylases. Structure 21, 98–108 (2013).

  5. 5.

    Chu, C. H. et al. KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor. J. Med. Chem. 57, 5975–5985 (2014).

  6. 6.

    Nestorov, P., Tardat, M. & Peters, A. H. H3K9/HP1 and Polycomb: two key epigenetic silencing pathways for gene regulation and embryo development. Curr. Top. Dev. Biol. 104, 243–291 (2013).

  7. 7.

    Zhang, T., Cooper, S. & Brockdorff, N. The interplay of histone modifications - writers that read. EMBO Rep. 16, 1467–1481 (2015).

  8. 8.

    Black, J. C. et al. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell 154, 541–555 (2013).

  9. 9.

    Yang, J. et al. The role of histone demethylase KDM4B in Myc signaling in neuroblastoma. J. Natl. Cancer Inst. 107, djv080 (2015).

  10. 10.

    Han, F. et al. JMJD2B is required for Helicobacter pylori-induced gastric carcinogenesis via regulating COX-2 expression. Oncotarget 7, 38626–38637 (2016).

  11. 11.

    Wilson, C. et al. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer. Oncogene 36, 2565–2576 (2017).

  12. 12.

    Chung, Y. G. et al. Histone demethylase expression enhances human somatic cell nuclear transfer efficiency and promotes derivation of pluripotent stem cells. Cell. Stem. Cell 17, 758–766 (2015).

  13. 13.

    Wang, J. et al. Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy. Cell Death Differ. 23, 1886–1896 (2016).

  14. 14.

    Wang, L. Y. et al. KDM4A coactivates E2F1 to regulate the PDK-dependent metabolic switch between mitochondrial oxidation and glycolysis. Cell Rep. 16, 3016–3027 (2016).

  15. 15.

    Young, L. C., McDonald, D. W. & Hendzel, M. J. Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following gamma-irradiation. J. Biol. Chem. 288, 21376–21388 (2013).

  16. 16.

    Li, H. et al. KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer. Oncotarget 7, 57866–57877 (2016).

  17. 17.

    Liu, W. et al. Identification of key factors conquering developmental arrest of somatic cell cloned embryos by combining embryo biopsy and single-cell sequencing. Cell Discov. 2, 16010 (2016).

  18. 18.

    Loh, Y. H., Zhang, W., Chen, X., George, J. & Ng, H. H. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 21, 2545–2557 (2007).

  19. 19.

    Wang, J. et al. The histone demethylase JMJD2C is stage-specifically expressed in preimplantation mouse embryos and is required for embryonic development. Biol. Reprod. 82, 105–111 (2010).

  20. 20.

    Shin, S. & Janknecht, R. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem. Biophys. Res. Commun. 359, 742–746 (2007).

  21. 21.

    Shi, L. et al. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc. Natl Acad. Sci. USA 108, 7541–7546 (2011).

  22. 22.

    Berry, W. L., Shin, S., Lightfoot, S. A. & Janknecht, R. Oncogenic features of the JMJD2A histone demethylase in breast cancer. Int. J. Oncol. 41, 1701–1706 (2012).

  23. 23.

    Coffey, K. et al. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover. Nucleic Acids Res. 41, 4433–4446 (2013).

  24. 24.

    Das, P. P. et al. Distinct and combinatorial functions of Jmjd2b/Kdm4b and Jmjd2c/Kdm4c in mouse embryonic stem cell identity. Mol. Cell 53, 32–48 (2014).

  25. 25.

    Pedersen, M. T. et al. Continual removal of H3K9 promoter methylation by Jmjd2 demethylases is vital for ESC self-renewal and early development. EMBO J. 35, 1550–1564 (2016).

  26. 26.

    Waugh, D. J. & Wilson, C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 14, 6735–6741 (2008).

  27. 27.

    Long, X. et al. IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review). Int. J. Oncol. 48, 5–12 (2016).

  28. 28.

    David, J. M., Dominguez, C., Hamilton, D. H., Palena, C. The IL-8/IL-8R axis: a double agent in tumor immune resistance. Vaccines (Basel) 4, 22 (2016).

  29. 29.

    Ha, H., Debnath, B. & Neamati, N. Role of the CXCL8-CXCR1/2 Axis in cancer and inflammatory diseases. Theranostics 7, 1543–1588 (2017).

  30. 30.

    Kido, S. et al. Interleukin 8 and vascular endothelial growth factor—prognostic factors in human gastric carcinomas? Eur. J. Cancer 37, 1482–1487 (2001).

  31. 31.

    Kuai, W. X. et al. Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells. World J. Gastroenterol. 18, 979–985 (2012).

  32. 32.

    Stein, B. & Baldwin, A. S. Jr. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol. Cell. Biol. 13, 7191–7198 (1993).

  33. 33.

    Aihara, M. et al. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect. Immun. 65, 3218–3224 (1997).

  34. 34.

    Yang, J. C. et al. Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients. Am. J. Gastroenterol. 92, 1316–1321 (1997).

  35. 35.

    Nishikawa, H., Hatakeyama, M. Sequence polymorphism and intrinsic structural disorder as related to pathobiological performance of the helicobacter pylori CagA oncoprotein. Toxins (Basel) 9, 136 (2017).

  36. 36.

    Hatakeyama, M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell. Host. Microbe 15, 306–316 (2014).

  37. 37.

    Kalisperati, P. et al. Inflammation, DNA damage, helicobacter pylori and gastric tumorigenesis. Front. Genet. 8, 20 (2017).

  38. 38.

    Brandt, S., Kwok, T., Hartig, R., Konig, W. & Backert, S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl Acad. Sci. USA 102, 9300–9305 (2005).

  39. 39.

    Wang, H. J., Cheng, W. C., Cheng, H. H., Lai, C. H. & Wang, W. C. Helicobacter pylori cholesteryl glucosides interfere with host membrane phase and affect type IV secretion system function during infection in AGS cells. Mol. Microbiol. 83, 67–84 (2012).

  40. 40.

    Eftang, L. L., Esbensen, Y., Tannaes, T. M., Bukholm, I. R. & Bukholm, G. Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. Bmc. Microbiol. 12, 9 (2012).

  41. 41.

    Lai, C. H. et al. Cholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells. Infect. Immun. 76, 3293–3303 (2008).

  42. 42.

    Ciaccio, M. F., Wagner, J. P., Chuu, C. P., Lauffenburger, D. A. & Jones, R. B. Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat. Methods 7, 148–155 (2010).

  43. 43.

    Szász, A. M. et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget 7, 49322–49333 (2016).

  44. 44.

    Labbé, R. M., Holowatyj, A. & Yang, Z.-Q. Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential. Am. J. Transl. Res. 6, 1–15 (2014).

  45. 45.

    Naumann, M. et al. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J. Biol. Chem. 274, 31655–31662 (1999).

  46. 46.

    Ding, S. Z., Smith, M. F. Jr. & Goldberg, J. B. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells. J. Gastroenterol. Hepatol. 23, e67–e78 (2008).

  47. 47.

    Nagy, T. A. et al. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J. Infect. Dis. 199, 641–651 (2009).

  48. 48.

    Ding, S. Z., Torok, A. M., Smith, M. F. Jr. & Goldberg, J. B. Toll-like receptor 2-mediated gene expression in epithelial cells during Helicobacter pylori infection. Helicobacter 10, 193–204 (2005).

  49. 49.

    Lai, C. H. et al. Helicobacter pylori CagA-mediated IL-8 induction in gastric epithelial cells is cholesterol-dependent and requires the C-terminal tyrosine phosphorylation-containing domain. FEMS Microbiol. Lett. 323, 155–163 (2011).

  50. 50.

    Segal, E. D., Cha, J., Lo, J., Falkow, S. & Tompkins, L. S. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl Acad. Sci. USA 96, 14559–14564 (1999).

  51. 51.

    Higashi, H. et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295, 683–686 (2002).

  52. 52.

    Kikuchi, K., Murata-Kamiya, N., Kondo, S. & Hatakeyama, M. Helicobacter pylori stimulates epithelial cell migration via CagA-mediated perturbation of host cell signaling. Microbes Infect. 14, 470–476 (2012).

  53. 53.

    Kwok, T. et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449, 862–866 (2007).

  54. 54.

    Ruoslahti, E. RGD and other recognition sequences for integrins. Annu. Rev. Cell. Dev. Biol. 12, 697–715 (1996).

  55. 55.

    Li, W. et al. Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer. Biochem. Biophys. Res. Commun. 416, 372–378 (2011).

  56. 56.

    Kim, S. J. et al. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia 3, 33–42 (2001).

  57. 57.

    Shi, J. & Wei, P. K. Interleukin-8: a potent promoter of angiogenesis in gastric cancer. Oncol. Lett. 11, 1043–1050 (2016).

  58. 58.

    Lee, K. E. et al. Helicobacter pylori and interleukin-8 in gastric cancer. World J. Gastroenterol. 19, 8192–8202 (2013).

  59. 59.

    Pollard, P. J. et al. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem. J. 416, 387–394 (2008).

  60. 60.

    Beyer, S., Kristensen, M. M., Jensen, K. S., Johansen, J. V. & Staller, P. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem. 283, 36542–36552 (2008).

  61. 61.

    Barczyk, M., Carracedo, S. & Gullberg, D. Integrins. Cell Tissue Res. 339, 269–280 (2010).

  62. 62.

    Meyer-ter-Vehn, T., Covacci, A., Kist, M. & Pahl, H. L. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J. Biol. Chem. 275, 16064–16072 (2000).

  63. 63.

    Zhang, J. et al. MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer. Am. J. Transl. Res. 10, 525–534 (2018).

  64. 64.

    Wei, Z. W. et al. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer. Cancer Lett. 359, 335–343 (2015).

  65. 65.

    Aldinucci, D. & Colombatti, A. The inflammatory chemokine CCL5 and cancer progression. Mediat. Inflamm. 2014, 292376 (2014).

  66. 66.

    Slee, R. B. et al. Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability. Oncogene 31, 3244–3253 (2012).

Download references

Acknowledgements

A special thanks to Dr. Pien-Chien Huang (Johns Hopkins University) for his valuable discussions and critical reading of the manuscript. This work was supported by MOST, NHRI, and NTHU-CGMH grants in Taiwan (MOST-104-2321-B-007-007, MOST-105-2314-B-007-001, NHRI-EX105-10517BI, 104N2748E1, and 105N717CV7).

Author information

Affiliations

  1. Institute of Molecular and Cellular Biology and Department of Life Science, National Tsing-Hua University, Hsinchu, 300, Taiwan

    • Meng-Chen Wu
    • , Hsin-Hung Cheng
    • , Yi-Chen Li
    • , Tsan-Jan Chen
    • , Wei Yang Sit
    •  & Wen-Ching Wang
  2. Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, 333, Taiwan

    • Ta-Sen Yeh
  3. Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, 350, Taiwan

    • Chih-Pin Chuu
  4. Department of Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA, 95616, USA

    • Hsing-Jien Kung
  5. Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, 350, Taiwan

    • Hsing-Jien Kung
  6. Institute of Engineering in Medicine, University of California, San Diego, La Jolla, CA, 92093, USA

    • Shu Chien

Authors

  1. Search for Meng-Chen Wu in:

  2. Search for Hsin-Hung Cheng in:

  3. Search for Ta-Sen Yeh in:

  4. Search for Yi-Chen Li in:

  5. Search for Tsan-Jan Chen in:

  6. Search for Wei Yang Sit in:

  7. Search for Chih-Pin Chuu in:

  8. Search for Hsing-Jien Kung in:

  9. Search for Shu Chien in:

  10. Search for Wen-Ching Wang in:

Contributions

W.C.W., H.J.K., and M.C.W. designed the study. S.C. contributed to signaling analysis. M.C.W., H.H.C., Y.C.L., and W.H.S. carried out the microarray analysis and cell-biology experiments. T.J.C. contributed to biochemical analysis. T.S.Y. provided clinical resources. C.P.C. carried out the Micro-Western array analysis. W.C.W., H.J.K., and S.C. wrote the manuscript with the comments from all authors.

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding authors

Correspondence to Hsing-Jien Kung or Wen-Ching Wang.

Supplementary information

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/s41419-019-1305-y